119 related articles for article (PubMed ID: 3731683)
1. Pharmacokinetic modeling of bidirectional transfer during peritoneal dialysis.
Janicke DM; Morse GD; Apicella MA; Jusko WJ; Walshe JJ
Clin Pharmacol Ther; 1986 Aug; 40(2):209-18. PubMed ID: 3731683
[TBL] [Abstract][Full Text] [Related]
2. Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.
Bliss M; Mayersohn M; Arnold T; Logan J; Michael UF; Jones W
Antimicrob Agents Chemother; 1986 Apr; 29(4):649-53. PubMed ID: 3707113
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
[TBL] [Abstract][Full Text] [Related]
4. Moxalactam epimer disposition in patients undergoing continuous ambulatory peritoneal dialysis.
Morse G; Janicke D; Cafarell R; Piontek K; Apicella M; Jusko WJ; Walshe J
Clin Pharmacol Ther; 1985 Aug; 38(2):150-6. PubMed ID: 4017417
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal transport of cefonicid.
Morse GD; Lane T; Nairn DK; Deterding J; Curry J; Gal P
Antimicrob Agents Chemother; 1987 Feb; 31(2):292-4. PubMed ID: 3566253
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
[TBL] [Abstract][Full Text] [Related]
8. Transperitoneal movement and pharmacokinetics of cefotiam and cefsulodin in patients on continuous ambulatory peritoneal dialysis.
Brouard R; Tozer TN; Merdjan H; Guillemin A; Baumelou A
Clin Nephrol; 1988 Oct; 30(4):197-206. PubMed ID: 3214965
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal and intravenous cefoperazone kinetics during continuous ambulatory peritoneal dialysis.
Keller E; Jansen A; Pelz K; Hoppe-Seyler G; Schollmeyer P
Clin Pharmacol Ther; 1984 Feb; 35(2):208-13. PubMed ID: 6692648
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
Dahl NV; Foote EF; Searson KM; Fein JL; Kapoian T; Steward CA; Sherman RA
Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
[TBL] [Abstract][Full Text] [Related]
12. Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis.
Veys N; Lameire N; Malerczyk V; Lehr KH; Rosenkranz B; Ringoir S
Clin Pharmacol Ther; 1993 Oct; 54(4):395-401. PubMed ID: 8222482
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
Bouchet JL; Albin H; Quentin C; de Barbeyrac B; Vinçon G; Martin-Dupont P; Potaux L; Aparicio M
Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal administration of acyclovir in patients receiving continuous ambulatory peritoneal dialysis.
Burgess ED; Gill MJ
J Clin Pharmacol; 1990 Nov; 30(11):997-1000. PubMed ID: 2243158
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
[TBL] [Abstract][Full Text] [Related]
16. Automated peritoneal dialysis: new implications for pharmacists.
Brophy DF; Mueller BA
Ann Pharmacother; 1997 Jun; 31(6):756-64. PubMed ID: 9184718
[TBL] [Abstract][Full Text] [Related]
17. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.
Somani P; Shapiro RS; Stockard H; Higgins JT
Clin Pharmacol Ther; 1982 Jul; 32(1):113-21. PubMed ID: 7083725
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.
Ahern MJ; Finkelstein FO; Andriole VT
Antimicrob Agents Chemother; 1976 Sep; 10(3):457-61. PubMed ID: 984787
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefodizime during continuous ambulatory peritoneal dialysis.
Mendes P; Lameire N; Rosenkranz B; Malerczyk V; Damm D
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():89-93. PubMed ID: 2074257
[TBL] [Abstract][Full Text] [Related]
20. Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis.
Steinhauer HB; Lubrich-Birkner I; Kluthe R; Baumann G; Schollmeyer P
Am J Nephrol; 1992; 12(1-2):61-7. PubMed ID: 1415367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
